Join
At 12.00 noon on
Ann will cover Ziccum’s formulating and drying technology LaminarPace, how it can turn delicate vaccines and biologics including mNRA into robust thermostable dry powders, the market opportunity for this, and the Company’s outstanding performance over the last 18 months.
Mail your questions ahead of the event here: kaarlo.airaxin@investortarget.se
Watch the event live here: https://youtube.com/live/qldbpqBV8Js?feature=share
© Modular Finance, source